The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helene, M.
Right arrow Articles by Kaplan, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helene, M.
Right arrow Articles by Kaplan, A. M.

The Journal of Immunology, Vol 158, Issue 11 5079-5082, Copyright © 1997 by American Association of Immunologists

ARTICLES

Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene

M Helene, V Lake-Bullock, JS Bryson, CD Jennings and AM Kaplan
Department of Microbiology and Immunology, Chandler Medical Center, University of Kentucky, Lexington 40536, USA. hlbullo@pop.uky.edu

Graft-vs-host disease (GVHD) after allogeneic bone marrow transplantation is associated with significant morbidity and mortality. T cell depletion of the marrow graft, which is currently used to prevent GVHD, has been shown to result in increased graft failure and leukemia relapse. To explore the feasibility of controlling GVHD, transgenic mice with the herpes simplex virus thymidine kinase suicide gene linked to the IL-2 promoter were used as a source of T cells to induce GVHD, which would be modulated with ganciclovir. Injection of herpes simplex virus thymidine kinase transgenic B10.A(5R) spleen cells into lethally irradiated DBA/2 mice resulted in severe acute GVHD. Treatment of the recipient mice with ganciclovir significantly inhibited GVHD-mediated weight loss and mortality and reduced the severity of inflammation in the target organs of GVHD.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. P. Rettig, J. K. Ritchey, J. L. Prior, J. S. Haug, D. Piwnica-Worms, and J. F. DiPersio
Kinetics of In Vivo Elimination of Suicide Gene-Expressing T Cells Affects Engraftment, Graft-versus-Host Disease, and Graft-versus-Leukemia after Allogeneic Bone Marrow Transplantation
J. Immunol., September 15, 2004; 173(6): 3620 - 3630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. R. Drobyski, M. Gendelman, S. Vodanovic-Jankovic, and J. Gorski
Elimination of Leukemia in the Absence of Lethal Graft-Versus-Host Disease After Allogenic Bone Marrow Transplantation
J. Immunol., March 15, 2003; 170(6): 3046 - 3053.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Litvinova, S. Maury, O. Boyer, S. Bruel, L. Benard, G. Boisserie, D. Klatzmann, and J. L. Cohen
Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease
Blood, August 28, 2002; 100(6): 2020 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M Merger, J L Viney, R Borojevic, D Steele-Norwood, P Zhou, D A Clark, R Riddell, R Maric, E R Podack, and K Croitoru
Defining the roles of perforin, Fas/FasL, and tumour necrosis factor {alpha} in T cell induced mucosal damage in the mouse intestine
Gut, August 1, 2002; 51(2): 155 - 163.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Liu, B. E. Anderson, M. E. Robert, J. M. McNiff, S. G. Emerson, W. D. Shlomchik, and M. J. Shlomchik
Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease
Blood, December 1, 2001; 98(12): 3367 - 3375.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Maury, B. Salomon, D. Klatzmann, and J. L. Cohen
Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice
Blood, November 15, 2001; 98(10): 3156 - 3158.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Cohen, O. Boyer, and D. Klatzmann
Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells
Blood, October 1, 2001; 98(7): 2071 - 2076.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. R. Drobyski, H. C. Morse III, W. H. Burns, J. T. Casper, and G. Sandford
Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene
Blood, April 15, 2001; 97(8): 2506 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Kornblau, I. Stiouf, V. Snell, D. Przepiorka, L. C. Stephens, R. Champlin, and F. C. Marini III
Preemptive Control of Graft-versus-Host Disease in a Murine Allogeneic Transplant Model Using Retrovirally Transduced Murine Suicidal Lymphocytes
Cancer Res., April 1, 2001; 61(8): 3355 - 3360.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
W. R. Drobyski, D. Majewski, K. Ozker, and G. Hanson
Ex Vivo Anti-CD3 Antibody-Activated Donor T Cells Have a Reduced Ability to Cause Lethal Murine Graft-Versus-Host Disease but Retain Their Ability to Facilitate Alloengraftment
J. Immunol., September 1, 1998; 161(5): 2610 - 2619.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.